Q3 2026
Oct 29, 2026
SNDL’s shares rose 1.6%, a relatively muted reaction to mixed results: adjusted operating income and free cash flow improved, but revenue and gross profit declined year over year. Cannabis Operations remained the main drag, and reported results included a CAD 52 million goodwill impairment.
Key takeaways
- Net revenue fell 2.5% year over year to CAD 238 million; gross profit declined 9.8% to CAD 57.9 million, and gross margin narrowed by two percentage points to 24.3%.
- Adjusted operating income turned positive at CAD 5.2 million, up CAD 14.8 million from a loss a year earlier. The reported operating loss was CAD 48.3 million, including a CAD 52 million non-cash goodwill impairment tied to Cannabis Operations.
- Free cash flow reached a quarterly record of CAD 20 million, up 19.5% year over year, but included a one-time CAD 10.6 million benefit from the initial captive-insurance unwind. SNDL expects a further CAD 8 million inflow in Q4.
- Cannabis Operations revenue declined CAD 10.3 million and gross profit fell CAD 6.6 million year over year. SNDL exited unprofitable domestic dried flower and initiated a strategic review of the segment.
- Cannabis Retail recorded quarterly net revenue and gross-margin records, while Liquor Retail achieved a gross-margin record; however, Liquor Retail revenue declined 3.3% to CAD 134.8 million.
Q2 2026
Aug 1, 2026
SNDL shares dropped 11.1% after disappointing investors with continued revenue declines, margin compression, and higher production ramp-up costs that pressured profitability across liquor and cannabis segments.
Key takeaways
- Net revenue declined 3.7% year-over-year to $235.8 million, led by a $7.2 million drop in liquor retail and $3.6 million in cannabis operations.
- Gross profit fell 16.6% to $56.3 million, with margins down 3.7 percentage points due to pressures in cannabis operations and liquor retail.
- Adjusted operating loss widened to $7 million, driven primarily by lower gross profit, new production ramp-up costs, and a $2.3 million SunStream valuation reduction.
- Free cash flow improved modestly by $1.2 million year-over-year to negative $6.7 million, despite seasonal headwinds and increased cash in transit.
- The company accelerated share repurchases, reducing shares outstanding by about 7% since late 2024, while maintaining a strong balance sheet with no debt and $183.2 million in unrestricted cash.
Q1 2026
Apr 30, 2026
Shares of SNDL fell 7.5% following Q1 earnings, as investors reacted negatively to declines in both the liquor and cannabis markets, worsening top-line contraction, and a drop in consolidated gross margins—particularly driven by weakness in cannabis operations. Persistent challenges in same-store sales and a year-over-year reduction in free cash flow added to concerns despite some margin gains in retail segments.
Key takeaways
- Net revenue declined 4.4% year-over-year to $196 million, reflecting contraction in the liquor and cannabis businesses.
- Gross profit fell by $3.8 million (down 6.8% year-over-year), with consolidated gross margin declining 70 basis points, attributed solely to ongoing softness in cannabis operations.
- Both adjusted and unadjusted operating income remained negative, though operating losses narrowed compared to the prior year on improved OpEx control and lack of prior SunStream write-downs.
- Free cash flow deteriorated to negative $7.6 million, a $6.5 million year-over-year decline, primarily due to working capital challenges in cannabis and higher CapEx.
- Management points to improvement initiatives and newly added exclusive production contracts, but expects revenue growth to return only in the second half of 2026 as easier comps and these measures take effect.
Q3 2025
Nov 4, 2025
SNDL reported a strong third quarter of 2025, achieving record free cash flow and positive cumulative free cash flow for the first nine months of the year, despite facing a reported operating loss due to noncash items.
Key takeaways
- Net revenue reached $244 million, a 3.1% year-over-year increase driven primarily by the Cannabis segment.
- Free cash flow stood at $16.7 million for Q3, marking a $7.5 million improvement compared to the previous year, and bringing year-to-date total to $7.7 million.
- Operating income was impacted by $11.9 million in noncash adjustments, including share-based compensation related to stock price increases.
- Continued investment in growth, with the acquisition of 32 cannabis stores pending regulatory approval and plans to open several new retail locations in Q4.
- Improvements in gross profit margins were countered by noncash inventory-related adjustments, highlighting operational challenges in the Cannabis Operations segment.